INS and obesity due to melanocortin 4 receptor deficiency: These results demonstrate that the effect of marked weight loss on metabolic function is heterogeneous and muscle insulin action (insulin-stimulated glucose disposal) does not improve in people with obesity who already have “normal” muscle insulin sensitivity.